Topical botanical Cinainu earned FDA Breakthrough Therapy status for AA in patients aged 2+, supported by phase 2/3 RAAINBOW data in children.
|Articles|April 12, 2012
Plant Contact Dermatitis
Author(s)Ted Rosen, MD, Ted Rosen, MD
Poison ivy, oak, or sumac? What is this "itchy rash" that appeared 2 days after the patient cleared some "weeds" from the yard. What should be done about it?
Advertisement
A patient presented for help with an “itchy rash” on the arms of 2 days’ duration. The eruption appeared after she had helped her parents clear thick overgrowths of “weeds” from the yard.
Key point: Almost the entire rash was composed of linear arrays of papules and small blisters. Pruritic linear vesicles are virtually always caused by plant contact dermatitis. Poison ivy, oak, and sumac are the most common causes, and they vary in prevalence by geographic area.
Treatment: Mild cases of very limited extent can be treated with twice-daily or three-times-daily application of a potent topical corticosteroid. More extensive disease requires a 2- to 4-week, tapering course of oral corticosteroids (such as prednisone, starting at 40 to 60 mg/d).
Note: Sensitivity to the rhus family of plants is essentially lifelong and difficult to completely eliminate, even following desensitization protocols.
Advertisement
Related to this article
Real-world claims show dupilumab was tied to a 33%-52% lower risk of atopic march progression vs systemic corticosteroids in children with AD.
Once-daily roflumilast cream 0.05% was well tolerated in infants 3 to <24 months with AD, with 34.4% reaching vIGA-AD success at week 4.
Oral icotrokinra kept PASI 90 rates at ≥72% and IGA 0/1 at ≥70% from week 64 to 112 in ICONIC-LEAD, with no new safety signals.
At AAP 2026, Peter Lio, MD, discussed distinguishing allergic and inflammatory skin conditions and when pediatricians should seek specialty care.
Oral icotrokinra sustained scalp, genital, and hand/foot psoriasis clearance through week 112 in ICONIC-TOTAL, with no new safety signals.
A 16-month-old with recurrent otitis media developed a spreading unilateral rash on her hip and thigh during antibiotic treatment. PCR testing confirmed herpes zoster, an uncommon diagnosis in young, vaccinated children.
Upadacitinib showed continued facial and body repigmentation in NSV through week 76, with numerically higher responses when combined with NB-UVB.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA sets new PDUFA date for Anaphylm for type I allergic reactions
2
Youth-onset type 2 diabetes may progress faster, signs easy to miss
3
When one young athlete’s cardiac arrest revealed a family at risk
4
SUID drives widening Black-White infant mortality gap since 2020
5